Related Experiment Video

Updated: Oct 18, 2025

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.7K

"Valve-sparing" transvenous defibrillator systems after tricuspid valve intervention

Evan Blank1, Anand D Shah1, Joshua M Rosenblum2

  • 1Emory University School of Medicine, Atlanta, Georgia.

Heart Rhythm
|September 28, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Implantable cardioverter-defibrillatorsTetralogy of FallotTricuspid valve

More Related Videos

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K

Related Experiment Videos

Last Updated: Oct 18, 2025

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.7K
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

67
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

52
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
52

Articles linked to this work by shared authors, journal, and citation graph.

A 33-Year Old with Wide Complex Tachycardia.

Cardiac electrophysiology clinics·2026

Variability and Main Determinants of Planning Target Volume During Cardiac Stereotactic Radioablation for Refractory Ventricular Arrhythmias: A Systematic Review and Pooled Analysis.

Journal of cardiovascular electrophysiology·2026

Branch Pulmonary Artery Reinterventions After Repair of Truncus Arteriosus.

Annals of thoracic surgery short reports·2026

HRS/ISACHD/PACES scientific statement on provider and institutional best practices for comprehensive adult congenital heart disease electrophysiology programs.

Heart rhythm·2026

Predicting Atrial Fibrillation Ablation Outcomes: Machine Learning Model Development and Validation Using a Large Administrative Claims Database.

JMIR cardio·2025

One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter Defibrillator.

Circulation. Arrhythmia and electrophysiology·2025

Heart failure risk stratification at the time of ICD implantation after myocardial infarction: the HF WICD-MI score.

Heart rhythm·2026

Relationship Between Areas of Delayed Trans-Septal Conduction Time and Critical Sites for Septal Ventricular Tachycardia in Non-Ischemic Cardiomyopathy.

Heart rhythm·2026

Tricuspid Regurgitation and Leadless Pacemakers: A State-of-the-Art Review.

Heart rhythm·2026

Combined Effects of Early Rhythm Control and Exercise on Atrial Fibrillation Outcomes: Nationwide Cohort Analysis.

Heart rhythm·2026

Fundamentals of Pulsed Field Ablation at the Individual Cardiomyocyte Level.

Heart rhythm·2026

Monopolar and Bipolar Pulsed Field Ablation: Impact of Application Repetition and Epicardial Fat on Ventricular Lesion Formation.

Heart rhythm·2026

Non-Invasive Methods for Identifying Electrical Responders to Conduction System Pacing Cardiac Resynchronization Therapy.

Pacing and clinical electrophysiology : PACE·2026

Bio-Compatible Flexible Memristive Devices Enabled by BNNT/MWCNT-ZnO Quantum Dot Hybrid Percolation Networks.

Small (Weinheim an der Bergstrasse, Germany)·2026

A Wearable Electrochemical Patch for Sustained Local Oxygen Therapy of Chronic Wounds.

Advanced materials (Deerfield Beach, Fla.)·2026

Emergence of Periodic Oscillations in Abiotic Proteinoid-Neurotransmitter Assemblies.

ACS applied bio materials·2026

Routine Electrothermal Bipolar Vessel Sealing for Recipient Iliac Lymphatic Control in Kidney Transplantation: A Prospective Initial Experience.

Transplantation proceedings·2026

Direct electrochemical modulation of the membrane potential enables insulin secretion control in pancreatic β-cells cultured on electrodes.

Bioelectrochemistry (Amsterdam, Netherlands)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us